Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.01
0.00 (0.00%)
At close: Aug 22, 2025, 3:59 PM
0.99
-2.05%
After-hours: Aug 22, 2025, 07:13 PM EDT
0.00% (1D)
| Bid | 0.96 |
| Market Cap | 101.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -30.41M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -3.74 |
| Forward PE | -2.81 |
| Analyst | Buy |
| Ask | 1.05 |
| Volume | 472,165 |
| Avg. Volume (20D) | 1,235,611 |
| Open | 1.00 |
| Previous Close | 1.01 |
| Day's Range | 0.99 - 1.05 |
| 52-Week Range | 0.33 - 1.53 |
| Beta | 1.48 |
About ONCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+34.1%
Oncolytics Biotech shares are trading higher after...
Unlock content with
Pro Subscription
4 months ago
+24.56%
Oncolytics Biotech shares are trading higher after the company secured up to $20 million in flexible funding for the development of Pelareorep through a share purchase agreement with Alumin Capital.
